Table 3.
The genes used in Real-time RT-PCR.
| Genes from the 51 gene list | ||
| Gene Symbol | Acc. number | validated |
| CCNB1IP1 | NM_182849 | yes |
| E2F2 | NM_004091 | yes |
| GGH | NM_003878 | yes |
| GIT2 | NM_014776 | yes |
| SERPINB9 | NM_004155 | yes |
| TMEM63A | NM_014698 | yes |
| ZNF497 | NM_198458 | no |
| ZNF691 | NM_015911 | no |
| Genes from the 94 gene list | ||
| Gene Symbol | Acc. number | validated |
| AKR1B1 | NM_001628 | yes |
| EGLN1 | NM_022051 | yes |
| HAX1 | NM_006118 | no |
| LGMN | NM_005606 | yes |
| SHC1 | NM_003029 | no |
| TFAP2A | NM_003220 | yes |
| Reference genes | ||
| Gene Symbol | Acc. number | |
| PPIA | NM_203431 | |
| PTER | NM_001001484 | |
Eight genes from the list of 51 genes (p < 0.001 and 80% presence) were selected together with six genes from the list with 94 genes (p < 0.01 and 100% presence), where p-values were below the significance level for the difference in average expression between 10 year survivors and deceased patients. Two genes were selected as reference genes since they had homogenous expression throughout the expression array analysis. The table also shows in which genes differences in expression between the two survival groups were validated using RT-PCR.